NEWS
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion
EMA
2026/06/26Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion
Summary
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion